Pancreatic Cancer Research

ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaActive in the last 2 years

Giovanni Brandi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0013-2858; OpenAlex author ID A5068055005. Sources: ClinicalTrials.gov.

Their work

Papers
12 (first author 0, last author 3)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers, 1 trial · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 12

  1. Classic versus innovative strategies for immuno-therapy in pancreatic cancer. Last author DOI 10.1016/j.addr.2025.115671↗
  2. The trend toward more target therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/14737140.2024.2357802↗
  3. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.01.016↗
  4. Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre. Co-author DOI 10.1007/s13304-022-01346-x↗
  5. Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes. Last author DOI 10.3390/cancers14102429↗
  6. The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies? Co-author DOI 10.3390/ijms22189914↗
  7. Hacking Pancreatic Cancer: Present and Future of Personalized Medicine. Last author DOI 10.3390/ph14070677↗
  8. Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells. Co-author DOI 10.1158/2159-8290.cd-19-1007↗
  9. Searching for novel multimodal treatments in oligometastatic pancreatic cancer. Co-author DOI 10.1186/s12885-020-06718-3↗
  10. Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000523↗
  11. Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. Co-author DOI 10.1097/mpa.0b013e3182a6486e↗
  12. Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer: A literature review and report of two cases. Co-author DOI 10.3892/ol.2011.253↗

Trials 1

  1. PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms. Principal investigator NCT06815172↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mariacristina Di Marco · 7 shared papers, 2011–2025 · strength 0.81
  2. Giorgio Frega · 3 shared papers, 2021–2022 · strength 0.46
  3. Chiara Deiana · 1 shared paper, 2024 · strength 0.31
  4. Elisa Giovannetti · 1 shared paper, 2024 · strength 0.31
  5. Alessandro Di Federico · 2 shared papers, 2021–2022 · strength 0.26
  6. Maria Giovanna Formelli · 1 shared paper, 2025 · strength 0.26
  7. Riccardo Casadei · 3 shared papers, 2011–2022 · strength 0.25
  8. Carla Serra · 2 shared papers, 2020–2022 · strength 0.23
  9. Florencia M. McAllister · 1 shared paper, 2021 · strength 0.19
  10. Giorgio Ercolani · 2 shared papers, 2016–2020 · strength 0.17
  11. Deborah Malvi · 1 shared paper, 2022 · strength 0.12
  12. Claudio Ricci · 1 shared paper, 2022 · strength 0.12
  13. Carlo Ingaldi · 1 shared paper, 2022 · strength 0.12
  14. Francesco Minni · 1 shared paper, 2022 · strength 0.12
  15. Maria Victoria Recouvreux · 1 shared paper, 2020 · strength 0.11
  16. Koen M.O. Galenkamp · 1 shared paper, 2020 · strength 0.11
  17. Yijuan Zhang · 1 shared paper, 2020 · strength 0.11
  18. Cosimo Commisso · 1 shared paper, 2020 · strength 0.11
  19. Elisa Grassi · 1 shared paper, 2020 · strength 0.11
  20. Claudio Ricci · 1 shared paper, 2020 · strength 0.11
  21. Daria Maria Filippini · 1 shared paper, 2020 · strength 0.11
  22. Raffaele Pezzilli · 2 shared papers, 2011–2016 · strength 0.08
  23. Marina Macchini · 2 shared papers, 2011–2014 · strength 0.06
  24. Guido Biasco · 2 shared papers, 2011–2014 · strength 0.06
  25. Alessandro Cucchetti · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.